You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Gilead Sciences, Inc. v. Lupin Limited
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in Gilead Sciences, Inc. v. Lupin Limited
The biologic drug covered by the patents cited in this case is ⤷  Sign Up .

Details for Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-16 1 trademark Atripla®. 16. United States.Patent No. 6,642,245 (“the ’245 Patent,” copy attached as Exhibit A), …Infringement of U.S. Patent No. 6,642,245 23. Plaintiffs repeat and reallege paragraphs 1-22 above as …Action l. This is an action for patent infringement under the patent laws of the United States, Title…the United States Patent and Trademark Office on Nover-nber 4, 2003. The ’245 Patent claims, inter alia…for Atripla®. 17. United States Patent No. 6,703,396 (“the ’396 Patent,” copy attached as Exhibit B), External link to document
2014-08-22 13 States Patent and Trademark Office (“PTO”), the PTO issued United States Patent No. 6,642,245 B1 (“the…Trademark Office issued U.S. Patent No. 6,642,245 B1 (“the ‘245 patent”), entitled “ANTIVIRAL ACTIVITY… U.S. Patent No. 6,642,245 23. Lupin restates and incorporates… the PTO issued United States Patent No. 6,703,396 B1 (“the ‘396 patent”), titled “METHOD OF RESOLUTION… Patents-in-Suit 8. On or about November 4, 2003, the United States Patent and Trademark External link to document
2014-08-05 8 2014. The patents-in-suit in the newly-filed case (U.S. Patent Nos. 6,703,396, and 6,642,245) are also…6,703,396 and claims 1, 2, 4 and 6 of U.S. Patent No. 6,642,245. Further, Lupin intends to stipulate to … same patent claims in this action as in No. 12-cv-6293_claims 1-7, 13, 15 and 16 ofU.S. Patent No. 6,… 17 September 2014 1:14-cv-05352 830 Patent Defendant District Court, S.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.